Tratamiento quirúrgico del hiperparatiroidismo secundario
DOI:
https://doi.org/10.31837/relatos/9Palabras clave:
hiperparatiroidismo, tiroides, enfermedades de la tiroides, tratamiento quirúrgico, enfermedad renal crónica, fisiopatología, timo, imagenología, localización intraoperatoria, localización preoperatoria, embriología, anatomíaResumen
...El Hiperparatiroidismo Secundario es una patología relacionada con la secreción excesiva de hormona paratiroidea,
por unas glándulas paratiroides hiperplásicas, siendo la causa más frecuente la Insuficiencia Renal Crónica.
Es todo un desafío transmitir conocimiento acerca del ¨Tratamiento Quirúrgico del Hiperparatiroidismo Secundario
¨, requiere conocimientos teóricos, de anatomía, embriología, patología y fisiopatología, pero esencialmente prácticos
sobre técnica y destreza quirúrgica que el cirujano debe poseer al momento de enfrentarse a dicho tratamiento.
Han sido pocos los cirujanos Uruguayos que se dedicaron a este tratamiento, algunos de los cuales nos dejaron muchas
enseñanzas que hemos adoptado y actualizado de acuerdo al estado del arte, durante todos estos años en los que nos
hemos dedicado a este maravilloso tema.
Estamos convencidos que el correcto manejo del ¨Tratamiento Quirúrgico del Hiperparatiroidismo Secundario¨,
habilita al cirujano para el tratamiento de las otras patologías del cuello, principalmente las relacionadas con la glándula
Tiroides. ...
Descargas
Citas
Cope O. The Story of Hyperparathyrodism at the Massachusetts General Hospital. N Engl J Med 1966; 274:1174
Ruda JM, Hollenbeak C, Stack B. A systematic review of diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005;132:359-372.
Martin KJ, Olgaard K, Coburn JW, et al. Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy, Am. J. Kidney Dis 2004;43: 558-565.
Cusumano A et al. 2000. Sobrevida prolongada en hemodiálisis: cómo vivir más alla de la primera década. Revnefrol diálisis transpl 50:5-14.
Owen R. On the anatomy of the Indian rhinoceros. Trans Zool Soc Lond. 1862; IV: 31-58.
Thompson NW. The history of hyperparathyroidism. Acta Chir Scand. 1990; 156: 5-21.
Sandström I. On a new gland in a man and several mammals (glandulae parahtyroideae). Upsala Lakforenings Forth. 1880; 15: 441-71.
Gley E. Sur les fonctions du corps thyroide. C R Seanc Soc Biol. 1891; 43: 841-3.
Mac Callum WG. The physiology and pathology of the parathyroid glands. Proc Pathol Soc Phil. 1908; 11:115-28. 128 9.
Mac Callum WG, Voetling C. On the relation of the parathyroid to calcium metabolism and the nature of tetany. Bull Johns Hopkins Hospital. 1908; 19: 91-2
Mandl F. Therapeutic trial in a case of osteitis fibrosa generalisata by means of removal of a parathyroid tumour. Presentation at the Medical Society of Vienna, December 4, 1925
Hannon RR, Shor E, McClellan WS, DuBois EF. A case of osteitis fibrosa cystica (osteomalacia?) with evidence of hyperactivity of the parathyroid bodies. Metabolic study I J Clin Invest. 1930; 8: 215-27
Albright F, Bloomberg E, Castleman B, Churchill ED. Hyperparathyroidism due to a diffuse hyperplasia of all parathyroid glands rather than to a parathyroid adenoma of one gland. Arch Int Med. 1934; 54: 315-29
Cope O, Keynes WM, Roth SI, Castleman B. Primary chief cell hyperplasia of the parathyroid glands. Ann Surg. 1958; 148: 375-88
Boonstra CE, Jackson CE. Hyperparathyroidism detected by routine serum calcium analysis. Ann Int Med. 1965; 63: 468-74.
Boonstra CE, Jackson CE. Serum calcium survey for hyperparathyroidism: result in 50,000 clinic patients. Am J Clin Pathol. 1971; 55 (5): 523-6En
Berson SA, Yallow RS, Aurbach GD, Potts JR. Immunoassay of bovine and human parathyroid hormone. Proc Natl USA. 1963; 49: 613-7.
Hop N Le, JA Norton. Surgical management of hyperparathyroidism. En: LJ de Groot, JL Jameson, editores. Endocrinology. 4ª ed. Philadelphia. WB Saunders Company; 2001. p.1111-20
Stanbury WS, Lumb GA, Nicholson WF. Elective Subtotal Parathyroidectomy for renal Hyperparathyroidism. Lancet 1960; 1:793
Wells SA, Ross AJ, Dale JR, Gray RS. Transplantaion of the Parathyroid glands. Currente Status. Surg Clin North AM 1979; 59: 167
Pyrah L, Hodgkinson A, Anderson C. Primary Hyperparathyrodism.Br J Surg 1966; 53:245
Purnell DC, Scholtz DA, Smith LM. Treatment of Primary Hyperparathyrodism. Am J Med 1974; 56:800
Romanus R, Heimann, Nilson O, Hansson G. Surgical Treatment of Primary Hyperparathyrodism. Prog Surg 1973; 12: 22
Cope O. Hyperparathyrodism. Diagnosis and Management. Am J Surg 1960; 99:394
Egdahl S. Surgery of Parathyroid Glands. Surg Gynecol Obstet 1970; 130:901
Cazaban LA, Del Campo A, Servetti E, Gomez Fossati C, Crestanello F.Aplicación Clínica del Implante de paratiroides. Cir Uruguay 1972; 40:16
Morelli R. Tratamiento Quirurgico de Hiperparatiroidismo. Cir Uruguay 1994; 64:257-274
Bileziquian J., Marcus R., Levine M. The Parathyroids: Basic and Clinical concepts. Edition 2°, New York: Raven. 2001, 881 pages.
Abboud B. Anatomie topographique et vascularisation arterièlle des parathyroïdes. Presse Med 1996; 25:1156-1161.
Geis N. The Parathyroids Glands. Annals of Surgery: April 1908; 47(4):523-531.
Sitges-Serra A., Sancho J. Cirugía Endocrina. Guías Clínicas de la Asociación Española de Cirujanos.
Wang C. The Anatomic Basis of Parathyroid Surgery. Ann. Surg. March. 1976: 183 (3):271–275
Cummings: Otolaryngology: Head & Neck Surgery, 4th ed. Mosby. 2005. Chapter 120
Delattre J.F., Flament J.B., Palot J.P., Pluot M. Les variations des parathyroïdes. Journal de Chirurgie 1982; 119 (11): 633-641
Phitayakorn R., McHenry C. Incidence and location of ectopic abnormal parathyroid glands.The American Journal of Surgery. 2006; 119:418–423.
Haldsten W., Evans H. The parathyroid glandules: their blood supply, and their preservation in operation upon the thyroid gland. Annals of Surgery. 1907; 46(4):489-506.
Tfelt-Hansen J, Brown EM. The calcium-sensing receptor in normal physiology and pathophysiology: a review. Crit Rev Clin Lab Sci [Internet]. 2005 [cited 2017 Aug 15];42(1):35–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15697170
Fraser WD. Hyperparathyroidism. Lancet (London, England). 2009;(374):145–58.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3:150.
Martínez-Castelao A, Górriz-Teruel JL, Bover-Sanjuán J, Segura-de la Morena J, Cebollada J, Escalada J, et al.Documento de consenso para la deteccion y manejo de la enfermedad renal crónica. Aten Primaria [Internet].2014;46(9):501–19. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24658201
Levey AS, Coresh J. Chronic kidney disease. Lancet [Internet]. 2012 Jan 14 [cited 2014 Jul 11];379(9811):165–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21840587
Brück K, Stel VS, Gambaro G, Hallan S, Völzke H, Ärnlöv J, et al. CKD Prevalence Varies across the European General Population. J Am Soc Nephrol [Internet]. 2016 Jul 1 [cited 2017 Aug 16];27(7):2135–47. Available from: http://www.jasn.org/cgi/doi/10.1681/ASN.2015050542
Delanaye P, Glassock RJ, De Broe ME. Epidemiology of chronic kidney disease: think (at least) twice! Clin Kidney J [Internet]. 2017 Jun [cited 2017 Aug 16];10(3):370–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28617483
González-Bedat C, Ferreiro-Funtes A, Chifflet-Bide L. Registro Uruguayo de Diálisis. INFORME ANUAL 2015. 2017; Available from: http://www.nefrologia.hc.edu.uy/images/Informme_RUD_año_2015.pdf
Rios P. Informe Programa de Salud Renal 2016 [Internet]. 2016. Available from: http://www.fnr.gub.uy/sites/default/files/programas/informe_renal_2016.pdf
Eckardt K-U, Kasiske BL. KDIGO Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int [Internet]. 2009
Aug [cited 2017 Aug 24];76(113):S1–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19644521
Canalejo R, Canalejo A, Martinez-Moreno JM, Rodriguez-Ortiz ME, Estepa JC, Mendoza FJ, et al. FGF23 fails to inhibit uremic parathyroid glands. J Am Soc Nephrol [Internet]. 2010 Jul 1 [cited 2017 Aug 31];21(7):1125–35. Available from: http://www.jasn.org/cgi/doi/10.1681/ASN.2009040427
Cunningham J, Locatelli F, Rodriguez M. Secondary Hyperparathyroidism: Pathogenesis, Disease Progression, and Therapeutic Options. Clin J Am Soc Nephrol [Internet]. 2011 Apr 1 [cited 2017 Aug 31];6(4):913–21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21454719
Tallon S, Berdud I, Hernandez A, Concepcion MT, Almaden Y, Torres A, et al. Relative effects of PTH and dietary phosphorus on calcitriol production in normal and azotemic rats. Kidney Int [Internet]. 1996 May [cited 2017 Aug 31];49(5):1441–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8731112
Rodriguez M, Martin-Malo A, Martinez ME, Torres A, Felsenfeld AJ, Llach F. Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol. Kidney Int [Internet]. 1991 Dec [cited 2017 Aug 31];40(6):1055–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1762306
Brown AJ, Ritter CS, Finch JL, Slatopolsky EA. Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: Role of dietary phosphate. Kidney Int [Internet]. 1999 Apr [cited 2017 Aug 31];55(4):1284–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10200992
Bellorin-Font E, Martin KJ, Freitag JJ, Anderson C, Sicard G, Slatopolsky E, et al. Altered adenylate cyclase kinetics in hyperfunctioning human parathyroid glands. J Clin Endocrinol Metab [Internet]. 1981 Mar [cited 2017 Aug 31];52(3):499–507. Available from: https://academic.oup.com/jcem/article-lookup/doi/10.1210/jcem-52-3-499
Canaff L, Hendy GN. Human Calcium-sensing Receptor Gene. J Biol Chem [Internet]. 2002 Aug 16 [cited 2017 Aug 31];277(33):30337–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12036954
Almaden Y, Canalejo A, Hernandez A, Ballesteros E, Garcia-Navarro S, Torres A, et al. Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro. J Bone Miner Res [Internet]. 1996 Jul 3 [cited 2017 Aug 31];11(7):970–6. Available from: http://doi.wiley.com/10.1002/jbmr.5650110714
Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, et al. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest [Internet].
Jun 1 [cited 2017 Aug 31];97(11):2534–40. Available from: http://www.jci.org/articles/view/118701 56) Zhang MYH, Wang X, Wang JT, Compagnone NA, Mellon SH, Olson JL, et al. Dietary phosphorus transcriptionally regulates 25-hydroxyvitamin D-1alpha-hydroxylase gene expression in the proximal renal tubule. Endocrinology [Internet]. 2002 Feb [cited 2017 Aug 31];143(2):587–95. Available from: https://academic.oup.com/endo/article-lookup/doi/10.1210/endo.143.2.8627 Tratamiento Quirúrgico del Hiperparatiroidismo Secundario
Imanishi Y, Inaba M, Nakatsuka K, Nagasue K, Okuno S, Yoshihara A, et al. FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int [Internet]. 2004 May [cited 2017 Aug 31];65(5):1943–6. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/15086938
Denda M, Finch J, Slatopolsky E. Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure. Am J Kidney Dis [Internet]. 1996 Oct [cited 2017 Aug 31];28(4):596–602. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8840952
Almaden Y, Felsenfeld AJ, Rodriguez M, Cañadillas S, Luque F, Bas A, et al. Proliferation in hyperplastic human and normal rat parathyroid glands: role of phosphate, calcitriol, and gender. Kidney Int [Internet]. 2003 Dec [cited 2017 Aug 31];64(6):2311–7. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0085253815496024
Kremer R, Bolivar I, Goltzman D, Hendy GN. Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology [Internet]. 1989 Aug [cited 2017 Aug 31];125(2):935–41. Available from: https://academic.oup.com/endo/article-lookup/doi/10.1210/endo-125-2-935
Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.J Clin Invest [Internet]. 1993 Sep 1 [cited 2017 Aug 31];92(3):1436–43. Available from: http://www.jci.org/articles/view/116720
Garfia B, Cañadillas S, Canalejo A, Luque F, Siendones E, Quesada M, et al. Regulation of parathyroid vitamin D receptor expression by extracellular calcium. J Am Soc Nephrol [Internet]. 2002 Dec [cited 2017 Aug 31];13(12):2945–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12444213
Shigematsu T, Kazama JJ, Yamashita T, Fukumoto S, Hosoya T, Gejyo F, et al. Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis [Internet]. 2004 Aug [cited 2017 Sep 1];44(2):250–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15264182
Hassan A, Durlacher K, Silver J, Naveh-Many T, Levi R. The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia. Am J Physiol Renal Physiol [Internet]. 2016 Feb 1[cited 2017 Sep 1];310(3):F217-21. Available from: http://ajprenal.physiology.org/lookup/doi/10.1152/ajprenal.00332.2015
Koh N, Fujimori T, Nishiguchi S, Tamori A, Shiomi S, Nakatani T, et al. Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun [Internet]. 2001 Feb 2 [cited 2017 Sep 1];280(4):1015–20. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0006291X00942268
Galitzer H, Ben-Dov IZ, Silver J, Naveh-Many T. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int [Internet]. 2010 Feb [cited 2017 Aug 31];77(3):211–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20016468
Isakova T, Wahl P, Vargas GS, Gutiérrez OM, Scialla J, Xie H, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int [Internet]. 2011 Jun [cited 2017 Sep 1];79(12):1370–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21389978
Hruska KA, Seifert M, Sugatani T. Pathophysiology of the chronic kidney disease – mineral bone disorder. Curr Opin Nephrol Hypertens. 2015;(24):303–9.
Babayev R, Nickolas TL. Bone Disorders in Chronic Kidney Disease: An Update in Diagnosis and Management. Semin Dial. 2015;28(6):645–53.
Jevtic V. Imaging of renal osteodystrophy. Eur J Radiol [Internet]. 2003 May [cited 2017 Sep 1];46(2):85–95. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12714225
Adams JE. Renal bone disease: radiological investigation. Kidney Int Suppl [Internet]. 1999 Dec [cited 2017 Sep 1];73:S38-41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10633462
Mazzaferro S, Pasquali M, Pirrò G, Rotondi S, Tartaglione L. The bone and the kidney. Arch Biochem Biophys [Internet]. 2010 Nov 1 [cited 2017 Sep 1];503(1):95–102. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20599669
Cournot-Witmer G, Zingraff J, Plachot JJ, Escaig F, Lefèvre R, Boumati P, et al. Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization. Kidney Int [Internet]. 1981 Sep [cited 2017 Sep 1];20(3):375–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7300127
Miller PD. Bone disease in CKD: A focus on osteoporosis diagnosis and management. Am J Kidney Dis [Internet]. Elsevier Inc; 2014;64(2):290–304. Available from: http://dx.doi.org/10.1053/j.ajkd.2013.12.018
Watanabe R, Lemos MM, Manfredi SR, Draibe SA, Canziani MEF. Impact of cardiovascular calcification in nondialyzed patients after 24 months of follow-up. Clin J Am Soc Nephrol [Internet]. 2010 Feb 1 [cited 2017 Sep 1];5(2):189–94. Available from: http://cjasn.asnjournals.org/cgi/doi/10.2215/CJN.06240909
London GM, Pannier B. Arterial functions: how to interpret the complex physiology. Nephrol Dial Transplant [Internet]. 2010 Dec 1 [cited 2017 Sep 1];25(12):3815–23. Available from: https://academic.oup.com/ndt/article-lookup/doi/10.1093/ndt/gfq614
Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Gonçalves M, et al. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant [Internet]. 2004 Jun 1 [cited 2017 Sep 1];19(6):1480–8. Available from: https://academic.oup.com/ndt/article-lookup/doi/10.1093/ndt/gfh217
Honkanen E, Kauppila L, Wikstrom B, Rensma PL, Krzesinski J-M, Aasarod K, et al. Abdominal aortic calcification in dialysis patients: results of the CORD study. Nephrol Dial Transplant [Internet]. 2008 Jul 16 [cited 2017 Sep 1];23(12):4009–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18676346
Oung ERICWY, Lbert JUMA, Atayathum SUS, Oodkin DAAG, Isoni ROLP, Ort FRKP. Predictors and consequences of altered mineral metabolism : The Dialysis Outcomes and Practice Patterns Study. 2005;67:1179–87.
Sun Y-P, Yang W-J, Li S-H, Han Y, Liu J. Clinical Epidemiology of Mineral Bone Disorder Markers in Prevalent Hemodialysis Patients in the Xinjiang Uyghur Autonomous Region in China. Biomed Res Int [Internet].
[cited 2017 Sep 5];2017:1–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28299319
Kim CS, Bae EH, Ma SK, Han SH, Lee KB, Lee J, et al. Chronic Kidney Disease-Mineral Bone Disorder in Korean Patients: a Report from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). J Korean Med Sci [Internet]. 2017 Feb [cited 2017 Sep 5];32(2):240–8. Available from: https://synapse.koreamed.org/DOIx.php?id=10.3346/jkms.2017.32.2.240
Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, et al. Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis [Internet]. 2008 Sep [cited 2017 Sep 6];52(3):519–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18514987
Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT, et al. The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: Association With Mortality in Dialysis Patients. Am J Kidney Dis [Internet]. 2005 Nov [cited 2017 Sep 6];46(5):925–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16253734
Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int [Internet]. 2006 Aug [cited 2017 Sep 6];70(4):771–80. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0085253815519959
Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, et al. Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int [Internet]. 2005 Mar [cited 2017 Sep 6];67(3):1179–87. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15698460
Russo D, Miranda I, Ruocco C, Battaglia Y, Buonanno E, Manzi S, et al. The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int [Internet]. 2007 Nov [cited 2017 Sep 6];72(10):1255–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17805238
Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int [Internet]. 2002 Jul [cited 2017 Sep 6];62(1):245–52. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0085253815485424
Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int [Internet]. 2005 Oct [cited 2017 sep 6];68(4):1815–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16164659
Barreto DV, Barreto F de C, de Carvalho AB, Cuppari L, Draibe SA, Dalboni MA, et al. Phosphate binder impact on bone remodeling and coronary calcification--results from the BRiC study. Nephron Clin Pract [Internet]. 2008 Nov 12 [cited 2017 Sep 6];110(4):c273-83. Available from: http://www.karger.com/?-doi=10.1159/000170783
Qunibi W, Moustafa M, Muenz LR, He DY, Kessler PD, Diaz-Buxo JA, et al. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis [Internet].
Jun [cited 2017 Sep 6];51(6):952–65. Available from: http://linkinghub.elsevier.com/retrieve/pii/S027263860800526X
Bellorin-Font E, Ambrosoni P, Carlini RG, Carvalho AB, Correa-Rotter R, Cueto-Manzano A, et al. Guías de práctica clínica para la prevención , diagnóstico , evaluación y tratamiento de los trastornos minerales y óseos en la enfermedad renal crónica ( TMO-ERC ) en adultos. Nefrologia. 2013;Supl(33):1–28.
Moe SM, Chertow GM, Coburn JW, Quarles LD, Goodman WG, Block GA, et al. Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int [Internet]. 2005 Feb [cited 2017 Sep 6];67(2):760–71. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0085253815505140
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis , Evaluation , Prevention , and Treatment of Chronic Kidney Disease – Mineral and Bone Disorder ( CKD-MBD ). 2017;7(1).
Wagner PK, Seesko HG, Rothmund M (1991) Replantation of cryopreserved human parathyroid tissue. World J Surg 15(6): 751–755 36.
Wells SA Jr, Ellis GJ, Gunnells JC, Schneider AB, Sherwood LM (1976) Parathyroid autotransplantation in primary parathyroid hyperplasia. N Engl J Med 295(2):57–62
Ogg CS (1967) Total parathyroidectomy in treatment of secondary (renal) hyperparathyroidism. Br Med J 4(5575):331–334
Nada Rayes, MD; Daniel Seehofer, MD; Ralf Schindler, PhD .Long-term Results of Subtotal vs Total Parathyroidectomy Without Autotransplantation in Kidney Transplant.. Arch Surg. 2008;143(8):756-761
Gürhan Sakman’, Cem Kaan Parsak’, Mustafa BalaF .Outcomes of Total Parathyroidectomy with Autotransplantation versus Subtotal Parathyroidectomy with Routine Addition of Thymectomy to both Groups: Single Center. Experience of Secondary Hyperparathyroidism.. Balkan MedJ, Vol. 31, No. 1, 2014
Parathyroidectomy for secondary hyperparathyroidism in chronic renal failure. Drs. JA Perez, M Gabrielli. 100) Rothmund M, Wagner PK, Schark C (1991) Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 1991 15(6):745–750
Kerstin L, Detlef K. Bartsch K, Sancho JJ, Guigard S. Surgical management of secondary hyperparathyroidism in chronic kidney disease—a consensus report of the EuropeanSociety of Endocrine Surgeons. Arch Surg (2015) 400:907–927
Lorenz K, Sekulla C, Dralle H (2013) Chirurgisches Management des renalen Hyperparathyreoidismus. Zentralbl Chir 138(Suppl 2):e47–e54
Schneider R, Slater EP, Karakas E, Bartsch DK, Schlosser K. (2012) Initial parathyroid surgery in 606 patients with renal hyperparathyroidism. World J Surg 36(2): 318-326
Schneider R, Bartsch DK, Schlosser K (2013) Relevance of bilateral cervical thymectomy in patients with renal hyperparathyroidism: analysis of 161 patients undergoing reoperative parathyroidectomy.World J Surg 37(9):2155–2161
Schlosser K, Veit JA, Witte S, Fernández ED. Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial.
Caccitolo JA, Farley DR, Van Heerden JA. The current role of parathyroid cryopreservation and autotransplantation in parathyroid surgery: an institutional experience. Surgery 122:1062, 1997
Wagner PK, Seesko HG, Rothmund M. Replantation of cryopreserved human parathyroid tissue. World J Surg 15: 751, 1991
Shepet K , Alhefdhi A, Usedom R, Sippel R, Chen H. Parathyroid cryopreservation after parathyroidectomy: a worthwhile practice?. Ann Surg Oncol. 2013 Jul;20(7):2256-60. doi: 10.1245/s10434-013-2941-6. Epub 2013 Mar 16.
Ulrich F, Steinmuller N, Rayes A. Cryopreserved Human Parathyroid Tissue: Cell cultures for in vitro testing function. Transplatation Proceedings, 33, 666-667 (2001)
Christopher R, McHenry MD, Deborah B. The effect of cryopreservation on Parathyroid cell viability and function. Am J Surg 174: 481-484. 1997
José Miguel Domínguez, Soledad Velasco, Ignacio Goñi. Utilidad de la PTH intraoperatoria como predictor de curación quirúrgica en hiperparatiroidismo primario. Rev Méd Chile 2009; 137: 1591-1596
New Trens in Parathyroid Surgery. Curr Probl Surg. 2010;47:958-1017
Barczynski M, Konturek A, Hubalewska-Dydejcczyk A et al. Evaluation of Halle, Miami, Rome an Viena intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy. Langenbecks Arch Surg 2009;394(5):843-9
Kellen BS, Chrsitopher R, McHenry MD. The role of transcervical thymectomy in patients with hyperparathyroidism. Am J Surg (2012)203, 292-296
Calender G, Grubs E, Vu T et al. The Fallen one: the inferior paratgyroid gland that descends into de mediastinum.J Am Coll Surg. Vol. 208, N°5, May 2009; 887-893
Morgan EG, Mikhail MS, Murray MJ. Manejo de la vía aérea. En: Anestesiología clínica. 4.a ed. México DF/Bogotá DC: Manual Moderno; 2007. p. 91---114.
Lahey FH, Hoover WB. Injuries to the recurrent laryngeal nerve in thyroid operations: Their management and avoidance. Ann Surg. 1938;108:545-62.
Dralle H, Sekulla C, Haerting J, Timmermann W, Neumann HJ,Kruse E, et al. Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery. 2004;136:1310---
Hermann M, Alk G, Roka R, Glaser K, Freissmuth M. Laryngeal recurrent nerve injury in surgery for benign thyroid diseases: Effect of nerve dissection and impact of individual surgeon in more than 27,000 nerves at risk.Ann Surg. 2002;235:261---8.
Jatzko GR, Lisborg PH, Müller MG, Wette VM. Recurrent nerve palsy after thyroid operations–Principal nerve identification and a literature review. Surgery. 1994;115:139---44.
Moley JF, Lairmore TC, Doherty GM, Brunt LM, DeBenedetti MK. Preservation of the recurrent laryngeal nerves in thyroid and parathyroid reoperations. Surgery. 1999;126:673---7.
Eisele DW. Intraoperative electrophysiologic monitoring of the recurrent laryngeal nerve. Laryngoscope.1996;106:443-9.
Barczynski M, Konturek A, Cichon S. Randomized clinical trial of visualization versusneuromonitoring of recurrent laryngeal nerves during thyroidectomy. Br J Surg.[Comparative Study Randomized Controlled Trial].2009;96:240-6.
Higgins TS, Grupta R, Ketcham AS, Sataloff RT, Wadsworth JT, Sinacori JT. Recurrent laryngeal nerve monitoring versus identification alone on post-thyroidectomy true vocal fold palsy: A meta-analysis. Laryngoscope. 2011;121:1009---17.
Dionigi G, Bacuzzi A, Boni L, Rausei S, Rovera F, Dionigi R. Visualization versus neuromonitoring of recurrent laryngeal nervesduring thyroidectomy: What about the costs? World J Surg.2012;36:748---54.
Solbiati L, Giagrande A, Pra LD, Bellotti E, Cantu P, et al. Percutaneous ethanol injection of parathyroid tumor under US guidance: Treatment for secondary hyperparathyroidism. Radiology 1985;155:607-10.
Fukagawa M, Kitaoka M, Yi H, Fukuda N, Matsumoto T, et al. Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 1994;68:221-8.
Solbiati L, Rizzatto G, Ballarati E, Ierace T, Crespi L. Practical implications of color Doppler sonography of parathyroid glands: study of 203 tumors. Radiology 1993;189:210.
Ferlin G, Borsato N, Camerani M, Conte N, Zoiti D. New perspectives in localizing enlarged parathyroids by technetium-thallium substraction scan. J Nucl Med 1983;24:438-41.
Ishibashi M, Nishida H, Okuda S, Suekane S, Hayabuchi N. Localization of parathyroid glans in hemodialysis patients using Tc-99 sestamibi imaging. Nephron 1998;78:48-53
Ferrer-Ramírez M, Amoros-Sebastia L, Cano Terol C. Valor diagnóstico de las técnicas de localización paratiroidea en la cirugía del hiperparatiroidismo primario. Acta Otorrinolaringol Esp. 2003; 54(2): 220-24
Arkles L, Jones T, Hicks R, De Luise M, Chou S. Impact of complementary parathyroide scintigraphy and ultrasonography on the surgical management of hyperparathyroidism. Surgery. 1996; 120(5): 845-51
Berber E, Parikh N, Ballen N, Garner C, Siperstein A. Factors contributing to negative parathyroid localization: an analysis of 1000 patients. Surgery. 2008; 144(1): 74-79
Markarian M, Yelin G, Aparicio R, Marino J. Utilidad del centellograma TC 99-Sestamibi en la detección de adenomas e hiperplasias de glándulas paratiroides. Rev. Argent. Radiol. 2005;69(1): 69-77
Coakley A, Kettle A, Wells C. Technetium-99-sestamibi- a new agent for parathyroid imaging. Nucl Med Commun. 1989;10(11): 791-4
Koong HN, Choong LH, Soo KC. The role of preoperative localization techniques in surgery for hyperparathyroidism.Ann Acad Med Singapure, 1998; 27: 192-195
Levin KE, Clark OH. Localization of parathyroid glands. Ann Rev Med. 1988; 39: 29-40
Weber AL, Randolph G, Aksoy FG. The Thyroid and Parathyroid Glands: CT and MR imaging and correlation with pathology and clinical findings. Radiol Clin North Am 2000; 38: 1105-1129
Otto D, Boerner AR, Hofmann M, Brunkhorst T, Meyer GJ, Petrich T, et al. Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET. Eur J Nucl Med Mol Imaging. 2004;31:1405–12. [PubMed]
Habener JF, Maunus R, Dee PC, Potts JT., Jr Early events in the cellular formation of proparathyroid hormone. ,J Cell Biol. 1980;85:292–8. [PMC free article] [PubMed]
Casas A, Burke G. Sathyanarayana M, Wei J. Prospective comparison of technetium-99m-sestamibi-iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal glands in patients with previously unoperated primary hyperparathyroidism. Am J Sug. 1993;166(4): 369-73
Perie S, Fessi H, Tassart M, Younsi N, Poli I, St Guily JL, et al. Usefuness of combination of high resolution ultrasonography and dualphase dual-isotope iodine 123/technetium Tc 99m sestamibi scintigraphy for the preoperative localization of hyperplastic parathyroid glands in renal hyperparathyroidism. Am J Kidney Dis 2005;45:344-52.
Mankoff DA. A definition of molecular imaging. J Nucl Med. 2007 Jun;48(6):18N, 21N.
Chen H, Mack E, Starling JR. Radioguided parathyroidectomy is equally effective for both adenomatous and
hyperplastic glands. Ann Surg. 2003 Sep;238(3):332-7; discussion 337-8
Pitt SC, Panneerselvan R, Sippel RS, Chen H. Radioguided parathyroidectomy for hyperparathyroidism in the reoperative neck. Surgery. 2009 Oct;146(4):592-8; discussion 598-9. doi: 10.1016/j.surg.2009.06.031.
Chen H, Sippel RS, Schaefer S. The effectiveness of radioguided parathyroidectomy in patients with negative technetium tc 99m-sestamibi scans. Arch Surg. 2009 Jul;144(7):643-8. doi: 10.1001/archsurg.2009.104.
Rubello D, Piotto A, Medi F, Gross MD, Shapiro B, Erba P, Mariani G, Pelizzo MR. ‘Low dose’ 99mTc-Sestamibi for radioguided surgery of primary hyperparathyroidism. Eur J Surg Oncol. 2005 Mar;31(2):191-6.
Beki? R, Celik P, Uysal B, Koçdor MA, Atila K, Saydam S, Harmancio?lu O, Durak H. Exposure of surgical staff in surgical probe applications in radioguided parathyroidectomy. Eur Arch Otorhinolaryngol. 2008 Dec;265(12):1545-8. doi: 10.1007/s00405-008-0716-7. Epub 2008 Jun 10.
Norman J. Recent trends becoming standard of care yielding smaller, more successful operations at a lower cost. Otolaryngol Clin North Am. 2004;37(4):683-688, vii.
Murphy C, Norman J. The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery. 1999;126(6):1023-1029.
Rubello D, Casara D, Giannini S, et al. Importance of radio-guided minimally invasive parathyroidectomy using hand-held gamma probe and low 99mTc-MIBI dose: technical considerations and long-term clinical results. Q J Nucl Med. 2003;47:224–232.
Rubello D, Casara D, Pelizzo MR. Symposium on parathyroid localization: optimization of peroperative procedures.Nucl Med Commun. 2003;24:133–140.
Norman J, Cheda H. Minimally invasive radioguided parathyroidectomy facilitatedby intraoperative nuclear mapping. Surgery. 1997;122:998–1004.
Kherlopian AR, Song T, Duan Q, et al. A review of imaging techniques for systems biology. BMC Syst Biol.2008;2(1):74.
Hadjipanayis CG, Jiang H, Roberts DW, Yang L.Current and future clinical applications for optical imaging of cancer: from intraoperative surgical guidance to cancer screening. Semin Oncol. 2011;38:109 –118.
Paras C, Keller M, White LM, Phay JE, Mahadevan-Jansen A. Nearinfrared auto-fluorescence for the detection of parathyroid glands. J Biomed Opt. 2011;16(6):067012.
McWade MA, Paras C, White LM, Phay JE, Mahadevan-Jansen A, Broome JT. A novel optical approach to intraoperative detection of parathyroid glands. Surgery. 2013;154(6):1371–1377.
Kim SW1, Song SH1, Lee HS1, Noh WJ1, Oak C1, Ahn YC1, Lee KD1. Intraoperative Real-Time Localization of Normal Parathyroid Glands With Autofluorescence Imaging. J Clin Endocrinol Metab. 2016 Dec;101(12):4646-4652.
Patel HP1, Chadwick DR, Harrison BJ, Balasubramanian SP. Systematic review of intravenous methylene blue in parathyroid surgery. Br J Surg. 2012 Oct;99(10):1345-51. doi: 10.1002/bjs.8814.
Rowley M, Riutort K, Shapiro D, Casler J, Festic E,Freeman WD. Methylene blue-associated serotonin syndrome:a ‘green’ encephalopathy after parathyroidectomy.Neurocrit Care 2009; 11: 88–93.
Pollack G, Pollack A, Delfiner J, Fernandez J. Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use. Laryngoscope 2009; 119: 1941–1946.
Bewick J, Pfleiderer A. The value and role of low dose methylene blue in the surgical management of hyperparathyroidism.Ann R Coll Surg Engl. 2014 Oct;96(7):526-9. doi: 10.1308/003588414X13946184903883.
Tummers QR, Schepers A, Hamming JF, Kievit J, Frangioni JV, van de Velde CJ, Vahrmeijer AL. Intraoperative guidance in parathyroid surgery using near-infrared fluorescence imaging and low-dose Methylene Blue. rgery. 2015 Nov;158(5):1323-30. doi: 10.1016/j.surg.2015.03.027.
Zaidi N, Bucak E, Okoh A, Yazici P, Yigitbas H, Berber E. The utility of indocyanine green near infrared fluorescentimaging in the identification of parathyroid glands during surgery for primary hyperparathyroidism. JSurg Oncol. 2016 Jun;113(7):771-4. doi: 10.1002/jso.24240. Epub 2016 Apr 4.
Cui L, Gao Y, Yu H, Li M, Wang B, Zhou T, Hu Q. Intraoperative Parathyroid Localization with Near-Infrared Fluorescence Imaging Using Indocyanine Green during Total Parathyroidectomy for Secondary Hyperparathyroidism.Sci Rep. 2017 Aug 15;7(1):8193. doi: 10.1038/s41598-017-08347-6.
Rodríguez-Gonzalez J, Ortiz S, Hernandez A, Claver M, Soria Cogollos T, Ramirez Romero A, et al. Utilidad y limitaciones del sestamibi99 TC como diagnóstico de localización en el hiperparatiroidismo. Cir. Esp. 1996;60(1): 400-3
Dubost C, Bouteloup P: Mediastinal exploration by sternotomy in surgery for hyperparathyroidism. 36 cases. J Chir 1988; 125: 631-637
